ESTRO 2024 - Abstract Book

S5685

RTT - Patient experience and quality of life

ESTRO 2024

is captured within the selection of PROMs used in this cohort of patients [6]. Therefore, the MDASI-HN questionnaire has been chosen for use within this HNC late effects clinic.

Assessing for missing concepts is an important part of selecting a PROM for use within clinical practice. As well as concept assessment, it is important to consider the construct and comprehensibility of the PROM so patients can understand what is being asked from them, and the PROM captures the outcome as intended [4]. The next stage of this research is for the RTT to present the MDASI-HN questionnaire to HNC patient focus groups, to confirm that the key stakeholders of this service find the PROM acceptable for use.

Keywords: PROMS, QOL, HNC

References:

1. Gormley, M., Creaney, G., Schache, A. et al. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J 233, 780–786 (2022). https://doi.org/10.1038/s41415-022-5166-x 2. Nilsen, M.L., Belsky, M.A., Scheff, N. et al. Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients. Curr. Treat. Options in Oncol. 21, 92 (2020). https://doi.org/10.1007/s11864-020 00797-x 3. Faithfull, S., A. Lemanska, and T. Chen, Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for Survivorship. Clin Oncol (R Coll Radiol), 2015. 27(11): p. 679-85. 4. Prinsen, C.A.C., et al., COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018. 27(5): p. 1147-1157. 5. The Royal College of Radiologists, National standard site-specific radiotherapy consent forms:development. 2021: London. 6. Burke, G., S. Faithfull, and H. Probst, Radiation induced skin reactions during and following radiotherapy: A systematic review of interventions. Radiography, 2022. 28(1): p. 232-239.

1752

Digital Poster

PPI in research: A thematic analysis determining information needs of radiotherapy patients

Siobhán Corish 1 , Ben Fulton 1 , Linda Galbraith 2 , Kirsty Coltart 3 , Anna Morris 2 , Aileen Duffton 1

1 Radiotherapy, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. 2 CRUK RadNet Glasgow, School of Cancer Sciences, Glasgow, United Kingdom. 3 Knowledge Services Beatson Library, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Purpose/Objective:

Radiotherapy (RT) is a key modality in the treatment of cancer for many patients (1). With increasing access to technological developments, RT has become more complex and this needs to be conveyed to patients. RT and cancer treatment can have a physical and psychological impact on patients. To ensure patient trust, value, and empowerment it is essential they are effectively informed before, during, and after RT. Our ethos is that working in partnership with a Cancer Research UK Radiotherapy Network patient and public involvement (CRUK-RadNet PPI) group enriches the design and conduct of local studies by including lived experience.